References
Llovet JM, Brú C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver dis. 1999;19:329–38.
Marrero JA, Kudo M, Bronowicki JP. The challenge of prognosis and staging for hepatocellular carcinoma. Oncologist. 2010;15(suppl 4):23–33.
Llovet JM1, Di Bisceglie AM, Bruix J. Design and endpoints of clinical trials in hepatocellular carcinoma. J Natl Cancer Inst. 2008;21;100(10):698–711.
Zhao YN, Zhang YQ, Ye JZ, et al. Hepatic resection versus transarterial chemoembolization for patients with Barcelona Clinic Liver Cancer intermediate stage Child-Pugh A hepatocellular carcinoma. Exp Ther Med. 2016;12(6):3813–9.
Lin C-L, Lin C-K, Lin T-J, et al. Comparison of surgical resection and trans arterial chemoembolization for patients with intermediate stage hepatocellular carcinoma. Journal of Cancer Research and Practice. 2016;3:334–8.
Liu W, Zhou JG, Sun Y. Hepatic resection improved the long-term survival of patients with BCLC stage B hepatocellular carcinoma in Asia: a systematic review and meta-analysis. J Gastrointest Surg. 2015;19(7):1271–80.
Yau T, Tang VY, Yao TJYau T. Development of Hong Kong Liver Cancer staging system with treatment stratification for patients with hepatocellular carcinoma. Gastroenterology. 2014;146(7):1691–700.
Sinn DH, Cho JY, Gwak GY, et al. Different survival of Barcelona clinic liver cancer stage C hepatocellular carcinoma patients by the extent of portal vein invasion and the type of extrahepatic spread. PLoS One. 2015;29;10(4):e0124434.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sonsuz, A. Barcelona Clinic Liver Cancer (BCLC) Staging: Does It Cover All Our Expectation. J Gastrointest Canc 48, 260–261 (2017). https://doi.org/10.1007/s12029-017-9963-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12029-017-9963-4